Biocryst Pharmaceuticals Inc · Depreciation & Amortization

Latest reported$5.95Mperiod endingJun 30, 2026

BCRX Depreciation & Amortization ($600.00K → $5.95M)

Annual Depreciation & Amortization

High-resolution chart · PNG

BCRX depreciation & amortization history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Depreciation & Amortization — Annual fiscal periods (USD)
Period ending	Depreciation & Amortization (USD)
Dec 31, 2025	1,389,000
Dec 31, 2024	1,246,000
Dec 31, 2023	1,655,000
Dec 31, 2022	1,437,000
Dec 31, 2021	777,000
Dec 31, 2020	748,000
Dec 31, 2019	724,000
Dec 31, 2018	770,000
Dec 31, 2017	704,000
Dec 31, 2016	483,000
Dec 31, 2015	180,000
Dec 31, 2014	177,000
Dec 31, 2013	304,000
Dec 31, 2012	628,000
Dec 31, 2011	886,000
Dec 31, 2010	2,267,369
Dec 31, 2009	1,612,514
Dec 31, 2008	1,625,878
Dec 31, 2007	1,369,713
Dec 31, 2006	821,195
Dec 31, 2005	864,567
Dec 31, 2004	969,449
Dec 31, 2003	1,101,000
Dec 31, 2002	1,246,618
Dec 31, 2001	1,049,435
Dec 31, 2000	669,214
Dec 31, 1999	500,000
Dec 31, 1998	500,000
Dec 31, 1997	600,000
Dec 31, 1996	500,000
Dec 31, 1995	600,000
Dec 31, 1994	600,000